Oncotarget

Reviews:

Transformation-associated recombination (TAR) cloning and its applications for gene function; genome architecture and evolution; biotechnology and biomedicine

Natalay Kouprina _ and Vladimir Larionov

PDF  |  Full Text  |  How to cite  |  Press Release

Oncotarget. 2023; 14:1009-1033. https://doi.org/10.18632/oncotarget.28546

Metrics: PDF 896 views  |   Full Text 2560 views  |   ?  


Abstract

Natalay Kouprina1 and Vladimir Larionov1

1 Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD 20892, USA

Correspondence to:

Natalay Kouprina, email: [email protected]

Keywords: transformation-associated recombination; TAR; microbes; biomedicine; biotechnology

Received: November 16, 2023     Accepted: November 27, 2023     Published: December 22, 2023

Copyright: © 2023 Kouprina and Larionov. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

ABSTRACT

Transformation-associated recombination (TAR) cloning represents a unique tool to selectively and efficiently recover a given chromosomal segment up to several hundred kb in length from complex genomes (such as animals and plants) and simple genomes (such as bacteria and viruses). The technique exploits a high level of homologous recombination in the yeast Sacharomyces cerevisiae. In this review, we summarize multiple applications of the pioneering TAR cloning technique, developed previously for complex genomes, for functional, evolutionary, and structural studies, and extended the modified TAR versions to isolate biosynthetic gene clusters (BGCs) from microbes, which are the major source of pharmacological agents and industrial compounds, and to engineer synthetic viruses with novel properties to design a new generation of vaccines. TAR cloning was adapted as a reliable method for the assembly of synthetic microbe genomes for fundamental research. In this review, we also discuss how the TAR cloning in combination with HAC (human artificial chromosome)- and CRISPR-based technologies may contribute to the future.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28546